Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xiaflex After Prior PRP for Peyronie's Disease
NCT05777031Phase 4Active, not recruiting
- Sponsor
- University of Miami
- Start
- Oct 2023
- Primary completion
- Jan 2027
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of collagenase clostridium histolyticum in Peyronie's disease, sponsored by University of Miami. Started Oct 2023; status: active, not recruiting.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
Peyronie's disease
Beyond the preview
Go deeper on NCT05777031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05777031.